Phase 3 study of cetirizine dry syrup in children suffering from perennial allergic rhinitis (Comparative study)
Phase 3
- Conditions
- Perennial Allergic Rhinitis
- Registration Number
- JPRN-jRCT2080220122
- Lead Sponsor
- GlaxoSmithKline K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Not specified
- Target Recruitment
- 286
Inclusion Criteria
Age: 3 to 14, Children with perennial allergic rhinitis, Patients eligible for evaluation of nasal symptom, etc.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the total nasal symptom score, safety, etc
- Secondary Outcome Measures
Name Time Method